Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

NCT01557842 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT01557842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01557842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
Lead sponsor
Biosense Webster, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
June 1, 2012
Completion date
March 19, 2014
Enrollment
15 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic, ventricular tachycardia